XT
ENSC icon

XTX Topco’s Ensysce Biosciences ENSC Stock Holding History

XTX Topco’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.3K Buy
77,005
+52,642
+216% +$19K ﹤0.01% 3885
2026
Q1 		$13.1K Buy
+24,363
New +$15.4K ﹤0.01% 3640
2025
Q4 		– Sell
-10,957
Closed -$26K – 3431
2025
Q3 		$26K Buy
+10,957
New +$23.6K ﹤0.01% 2281
2024
Q3 		– Sell
-882
Closed -$6.7K – 2219
2024
Q2 		$6.7K Buy
+882
New +$8.04K ﹤0.01% 1728

Other funds holding ENSC

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TIAM2
Tru Independence Asset Management 2 Portland, Oregon $185M AUM 20.3% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

XTX Topco's ENSC Position: Q2 2026 in Review

XTX Topco increased its Ensysce Biosciences (ENSC) stake by 216% in Q2 2026, buying an estimated $19K and bringing the position to 77,005 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3885.

XTX Topco first reported a position in ENSC in Q2 2024 and has held it in 4 quarters since. The position peaked at $26K in Q3 2025. 18 funds tracked by Wall St. Rank hold ENSC as of Q2 2026.

  • XTX Topco held 77,005 shares of Ensysce Biosciences worth $22.3K as of Q2 2026.
  • XTX Topco bought 52,642 Ensysce Biosciences shares in Q2 2026, an estimated $19K.
  • Ensysce Biosciences made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3885 holding.
  • XTX Topco first reported a position in Ensysce Biosciences in Q2 2024 and has held it in 4 quarters since.
  • XTX Topco's Ensysce Biosciences position peaked at $26K in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.